Ambrx Biopharma Cayman, Inc. Annual Revenues in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Revenues history and growth rate from 2019 to 2022.
  • Ambrx Biopharma Cayman, Inc. Revenues for the quarter ending June 30, 2023 was $1.12M, a 13.5% decline year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Revenues for 2022 was $7.4M, a 0.71% decline from 2021.
  • Ambrx Biopharma Cayman, Inc. annual Revenues for 2021 was $7.46M, a 45.5% decline from 2020.
  • Ambrx Biopharma Cayman, Inc. annual Revenues for 2020 was $13.7M, a 32.6% increase from 2019.
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $7.4M -$53K -0.71% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $7.46M -$6.22M -45.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $13.7M +$3.36M +32.6% Jan 1, 2020 Dec 31, 2020 20-F 2022-04-26
2019 $10.3M Jan 1, 2019 Dec 31, 2019 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.